Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine

Israeli study finds 94% drop in symptomatic COVID-19 cases with Pfizer vaccine

By Excelsio Media on February 15, 2021 Also in covid-19, Israel, Pfizer, vaccine

Israel’s largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer’s vaccine in the country’s biggest study to date.

Comments

Comentarios de Facebook

Subscribe to: Post Comments (Atom)